Definition of Guselkumab. Meaning of Guselkumab. Synonyms of Guselkumab

Here you will find one or more explanations in English for the word Guselkumab. Also in the bottom left of the page several parts of wikipedia pages related to the word Guselkumab and, of course, Guselkumab synonyms and on the right images related to the word Guselkumab.

Definition of Guselkumab

No result for Guselkumab. Showing similar results...

Meaning of Guselkumab from wikipedia

- Guselkumab, sold under the brand name Tremfya, is a monoclonal antibody against interleukin-23 used for the treatment of plaque psoriasis, psoriatic arthritis...
- use of hydroxyurea in chronic palmoplantar pustulosis. Treatment with guselkumab, an anti–interleukin 23 monoclonal antibody has shown a decrease in the...
- www.medicalnewstoday.com. 2021-08-15. Retrieved 2021-10-01. "Study: Guselkumab More Effective Than Secukinumab in Certain Subpo****tions". Dermatology...
- IL-23 Agonists: Interleukin 23 (SGRF) Antibodies: Brazikumab Briakinumab Guselkumab Risankizumab Tildrakizumab Ustekinumab IL-27 Agonists: Interleukin 27...
- the target of the FDA-approved ustekinumab. In 2017 the US FDA approved guselkumab for plaque psoriasis. There have been few studies of the efficacy of anti-TNF...
- the first of MorphoSys’ platform drugs received US marketing approval. Guselkumab (brand name Tremfya), which was developed and is being commercialized...
- Brodalumab L04AC13 Ixekizumab L04AC14 Sarilumab L04AC15 Sirukumab L04AC16 Guselkumab L04AC17 Tildrakizumab L04AC18 Risankizumab L04AC19 Satralizumab L04AC20...
- IL-23 Agonists: Interleukin 23 (SGRF) Antibodies: Brazikumab Briakinumab Guselkumab Risankizumab Tildrakizumab Ustekinumab IL-27 Agonists: Interleukin 27...
- IL-23 Agonists: Interleukin 23 (SGRF) Antibodies: Brazikumab Briakinumab Guselkumab Risankizumab Tildrakizumab Ustekinumab IL-27 Agonists: Interleukin 27...
- IL-23 Agonists: Interleukin 23 (SGRF) Antibodies: Brazikumab Briakinumab Guselkumab Risankizumab Tildrakizumab Ustekinumab IL-27 Agonists: Interleukin 27...